EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Arian Resources Corp. (ARC) fair value: what the stock is really worth

We calculate from audited financials what Arian Resources Corp. is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Jun 23, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · CA

AR Thin data Jun 23, 2026

Arian Resources Corp.

ARC · V

Low PriorityFair Value upside is limited and quality is weak.

·Fair value C$0.0100 · Fairly valued (+0%)
!Quality 21/100
!Weak Growth (revenue 3y −61.8 %/yr)
!Negative equity (buybacks among others) · negative free cash flow
!Trails peers (2/6)
!Narrow moat 5/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

C$0.5000 C$0.0100 Fair Value C$0.0100 May 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 23, 2026.

How to read this chart

60‑month range C$0.0100 – C$0.5000 · fair‑value band C$0.0100 – C$0.0200 · the C$0.0100 price screens below the C$0.0100 fair value. Dashed = 300-day average. As of Jun 23, 2026.

Follow Arian Resources in your weekly email

Every Wednesday you see whether Arian Resources is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services.

Show more

ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty health solutions such as TB and titer, pregnancy - related, respiratory/allergy, and blood type testing services, as well as vaccine, vitamin and supplements injections. It also provides drug, alcohol, and on-site mobile testing; paternity and DNA services; STD; and dry eyes testing services. In addition, the company offers employer solutions consisting of DOT solutions, background screening, HR employment solutions, and employee assistance programs. Further, it provides marketing, technology, and training services. The company provides services to individuals, companies, and legal and healthcare professionals. The company was formerly known as RSI International Systems Inc. ARCpoint Inc. was founded in 1998 and is headquartered in Greenville, South Carolina.

Stock analysis

Arian Resources Corp. (ARC) currently trades at C$0.0100, while our model-based Fair Value estimate is C$0.0100, implying the stock looks roughly 0.0% fairly valued today.

Show more

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 92/100, which puts the evidence level at low.

Scenario range: C$0.0100 (bear) to C$0.0200 (bull), the price of C$0.0100 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 21/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Arian Resources Corp. reported revenue of $606K in FY2025 versus $19.2M in FY2021, a compound −57.8%/yr. Reported net income was −$2.1M in FY2025.

Key figures

Market cap C$642K (≈ $455K) · P/S ratio 1.06 · EPS (TTM) C$−0.0300 · Return on assets (EBIT) −59.6% · Operating margin −154% · Revenue (TTM) C$606K · Revenue growth (YoY) −85.0% · Free cash flow −C$1.3M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 25 out of 100 (low confidence).

What moves the price

The share trades about 75% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at 0%, ARC screens cheaper than that median.

Notify me when ARC reaches fair value

Put ARC on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 21/100

Of which business quality 22 · Market factors (momentum, volatility) 28

Profitability 9
Margins and returns on capital today
Quality Growth 25
Are margins and returns improving?
Cashflow 27
Earnings quality: real cash, not paper profit
Fin. Strength 0
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 29
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−89.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−61.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
30.3% (2021) → −424.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch ARC, get fair value alerts →

Compare Arian Resources Corp. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 141 stocks

Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 21 · Bottom 25%
Fair Value upside +0% · Above median
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −51% · Bottom 25%
Operating margin (TTM) −154% · Bottom 25%
Growth and dividend
Revenue growth −85% · Bottom 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Diagnostics & Research median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM) 0.75× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)33 · sector 0
FUTURE (revenue growth)0 · sector 25
PAST (return on equity)0 · sector 9
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)0 · sector 30

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Thermo Fisher Scientific Inc TMO $658.52 $682.58 +4%
Danaher Corporation DHR $221.09 $207.76 −6%
WuXi AppTec Co 2359 HK$207.60 HK$228.36 +10%
Lonza Group LONN CHF 562.80 CHF 151.69 −73%
IDEXX Laboratories, Inc IDXX $521.50 $495.84 −5%
Agilent Technologies, Inc A $167.26 $63.90 −62%
Waters Corporation WAT $425.74 $106.31 −75%
IQVIA Holdings IQV $270.09 $295.80 +10%
Illumina, Inc ILMN $247.46 $272.21 +10%
Mettler-Toledo International Inc MTD $1,491 $635.75 −57%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Arian Resources Corp. Fair Value". https://www.fairvalue-calculator.com/stock/ARC

Frequently asked questions

Is Arian Resources Corp. (ARC) overvalued or undervalued?
As of Jun 23, 2026, our model estimates a fair value of C$0.0100 versus a price of C$0.0100, about +0% upside (fairly valued).
What is the fair value of ARC?
Our model-based fair value for Arian Resources Corp. is C$0.0100 (as of Jun 23, 2026), built from audited fundamentals. The current price: C$0.0100.
What is the quality score of ARC?
Arian Resources Corp. has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Arian Resources Corp. (ARC)?
Our model-based price target is the fair value of C$0.0100 (as of Jun 23, 2026) from 3 valuation models. Cautious scenario C$0.0100, optimistic scenario C$0.0200. It is a calculation from audited fundamentals, not an analyst target.
What is the Arian Resources Corp. stock forecast for 2026?
Our models put fair value at C$0.0100, about +0% upside versus a price of C$0.0100 (fairly valued). Cautious scenario C$0.0100, optimistic scenario C$0.0200. The calculation is refreshed regularly with new filings.
What is the revenue of Arian Resources Corp. (ARC)?
Arian Resources Corp. reported trailing-twelve-month revenue of about C$606K (latest available figure, as of Jun 23, 2026).
What is the intrinsic value of Arian Resources Corp. (ARC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Arian Resources Corp. it is C$0.0100 per share (as of Jun 23, 2026), against a price of C$0.0100. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is Arian Resources Corp. stock overvalued or undervalued in 2026?
As of Jun 23, 2026, ARC trades below its calculated fair value: price C$0.0100, fair value C$0.0100, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ARC?
No. The price is what the market pays today (C$0.0100); the fair value is what the company's own numbers justify (C$0.0100). For Arian Resources Corp. the two are C$0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Arian Resources Corp. worth?
The market values Arian Resources Corp. at about C$642K (market capitalisation, as of Jun 23, 2026). Per share that is C$0.0100; our models calculate a fair value of C$0.0100 per share.
What do the bullish and bearish scenarios say about ARC?
Our models span a range for Arian Resources Corp.: cautious scenario C$0.0100, base C$0.0100, optimistic C$0.0200 per share (as of Jun 23, 2026, price C$0.0100). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Arian Resources Corp. (ARC)?
Balance-sheet figures for Arian Resources Corp. (as of Jun 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 21/100, which measures business quality independently of the share price.
How far is ARC from its 52-week high?
Arian Resources Corp. trades at C$0.0100, about 75% below its 52-week high of C$0.0400 and at the low of C$0.0100 (as of Sep 21, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.0100 is for.
Which stocks are comparable to Arian Resources Corp.?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Arian Resources Corp. stock attractive at the current price?
The data as of Jun 23, 2026: price C$0.0100, calculated fair value C$0.0100 (+0%), Quality Score 21/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ARC calculated?
We run Arian Resources Corp. through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$0.0100, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Arian Resources Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Arian Resources Corp. (ARC)?
The closing price on Sep 21, 2026 was C$0.0100. Our model-based fair value is C$0.0100, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Arian Resources Corp. right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (C$0.0100 to C$0.0200) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Arian Resources Corp.

How large is the market capitalisation of Arian Resources Corp. (ARC)?
The market capitalisation of Arian Resources Corp. is C$642K (≈ $455K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Arian Resources Corp. (ARC)?
The price-to-sales ratio of Arian Resources Corp. is 1.06 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Arian Resources Corp. (ARC)?
Earnings per share at Arian Resources Corp. are C$−0.0300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the EBIT return on assets of Arian Resources Corp. (ARC)?
On an EBIT basis the return on assets of Arian Resources Corp. is −59.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Arian Resources Corp. (ARC)?
The operating margin of Arian Resources Corp. is −154% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Arian Resources Corp. (ARC)?
Revenue at Arian Resources Corp. is growing −85.0% versus a year earlier (3y avg −61.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Arian Resources Corp. (ARC) generate?
The free cash flow of Arian Resources Corp. is −C$1.3M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Arian Resources Corp. (ARC) carry?
The net debt of Arian Resources Corp. is C$8.5M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Arian Resources Corp. in the live analysis

One click puts Arian Resources Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.